HABRI Central - Resources: CRISPR/Cas9 Technology in Translational Biomedicine: About

The Human Animal Bond Research Institute (HABRI) is issuing a call for research proposals from institutions and organizations across the globe to investigate the health outcomes of pet ownership and/or animal-assisted interventions (AAI), both for the people and the animals involved. To learn more, visit https://habri.org/grants/funding-opportunities/ close

 
You are here: Home / Journal Articles / CRISPR/Cas9 Technology in Translational Biomedicine / About

CRISPR/Cas9 Technology in Translational Biomedicine

By E. I. Leonova, R. R. Gainetdinov

View Resource (HTM)

Licensed under

Category Journal Articles
Publication Title Cell Physiol Biochem
Volume 54
Issue 3
Pages 354-370
ISBN/ISSN 1015-8987
DOI 10.33594/000000224
Language eng
Author Address Institute of Translational Biomedicine St. Petersburg State University, Saint Petersburg, Russia.University of Science and Technology, Sochi, Russia, 1102.elena@gmail.com.St. Petersburg State University Hospital, St. Petersburg State University, Saint Petersburg, Russia.
Cite this work

Researchers should cite this work as follows:

Tags
  1. Animal models
  2. Animals
  3. Diseases
  4. DNA
  5. Gene expression
  6. Genetic engineering
  7. Genetics
  8. Humans
  9. RNA